Neurotrack, a Redwood City, California-based digital health company, raised $21m in Series C funding.
The round, which brings total funding to date to more than $50m, was led by existing investor Khosla Ventures, with participation from Dai-ichi Life, SOMPO Holdings, Sozo Ventures, Rethink Impact, and AME Cloud Partners.
The company intends to use the funds to drive adoption of its Memory Health Program, and continue development and partnerships in global markets.
Co-founded in 2012 by CEO Elli Kaplan, Stuart Zola, PhD, Elizabeth Buffalo, PhD, and Cecelia Manzanares, Neurotrack is a digital health company advancing programs to assess, preserve, and strengthen their memory health.
Last year, the company joined forces with Dai-ichi Life, a larges life insurance company in Japan, to make its novel products available to customers as part of its new dementia insurance product. And in the first part of 2019, SOMPO conducted a 16-week pilot with Neurotrack, where more than 550 of SOMPO’s employees took its test and followed the Memory Health Program for four months.
Neurotrack and SOMPO are now working to deepen and extend their partnership.